A Phase 1, Open-label, Randomized, Three-cohort, Two-period Crossover Study to Determine the Relative Bioavailability of Testosterone Following Application of Two Testosterone Transdermal Spray (TTS) Formulations Once Daily and Intrinsa Patch Twice Weekly in Healthy, Surgically and Naturally Post-menopausal Women Receiving Estrogen Replacement Therapy.

Trial Profile

A Phase 1, Open-label, Randomized, Three-cohort, Two-period Crossover Study to Determine the Relative Bioavailability of Testosterone Following Application of Two Testosterone Transdermal Spray (TTS) Formulations Once Daily and Intrinsa Patch Twice Weekly in Healthy, Surgically and Naturally Post-menopausal Women Receiving Estrogen Replacement Therapy.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 07 Jun 2011

At a glance

  • Drugs Testosterone (Primary)
  • Indications Female sexual dysfunction
  • Focus Pharmacokinetics
  • Sponsors VIVUS
  • Most Recent Events

    • 07 Jun 2011 Planned end date changed from 1 Nov 2010 to 1 Apr 2010 as reported by ClinicalTrials.gov.
    • 28 Apr 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 05 Apr 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top